Dynamics of Mineralization During Bone Development

Mineralization is an important process in bone growth, development and regeneration. Mineral deposition and crystallization in tissue are protein-mediated processes where the properties of the mineral are largely dictated by the function of specific proteins. Currently, the mechanism of mineralization is a hotly debated topic. The focus of this thesis is to better understand the dynamic process of mineral formation in bone and to identify physiological influences that affect the mineral pathway or the mineral product. First, the effect of carbonate substitution on crystal properties was explored using a series of B-type carbonated apatites (0.2–10.5 wt% CO₃ ^2-). It was determined that apatite crystal size is dependent on carbonate substitution due to the amount of strain it puts on the crystal lattice. Next, mineralization kinetics was observed in actively mineralizing ex vivo neonatal murine calvaria using Raman spectroscopy as a real-time monitor of mineral properties. Periodic deposition of apatitic mineral occurred with near-daily frequency for up to 6 days. Timing of the mineral events were compared to the expression of circadian-clock component Period1 using a firefly luciferase bioluminescence reporter gene. The calvaria most actively deposited mineral in the early evening around 9pm. These experiments were repeated in calvaria infected with an adenovirus carrying the bone sialoprotein (BSP) gene. The resulting overexpression of BSP significantly modified the mineralization pathway. BSP induced formation of amorphous calcium phosphate during the first 30 hours followed by a transformation into small hydrated crystals over 40 hours duration. Mineral growth was also observed in fractured murine tibiae after 5 weeks of healing. Both wild-type and Brtl/- mice were screened for mineral crystallinity and carbonate content. Brtl/- mice experienced a delay in mineralization by containing underdeveloped mineral with poor crystallinity and high carbonate content. Lastly, fresh murine femora were frozen and thawed several times to test the consistency of Raman bone quality metrics through the preservation of unfixed bone tissue. Collagen-matrix metrics were significantly affected after four freeze/thaw cycles. Mineral metrics were also affected but to a lesser degree. For Raman studies of fresh bone, one freeze/thawing is recommended.

Year	Entry
2000	Rauch F, Travers R, Parfitt AM, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. June 2000;26(6):581-589.
2004	Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. April 24, 2004;363(9418):1377-1385.
2010	Nudelman F, Pieterse K, George A, Bomans PHH, Friedrich H, Brylka LJ, Hilbers PAJ, de With G, Sommerdijk NAJM. The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater. December 2010;9(12):1004-1009.
2010	Boskey AL, Coleman R. Aging and bone. J Dent Res. December 2010;89(2):1333-1348.
2006	Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RGG, Ebetino FH. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone. May 2006;38(5):617-627.
2010	Dallas SL, Bonewald LF. Dynamics of the transition from osteoblast to osteocyte. Annals NY Acad Sci. March 2010;1192(1):437-443.
2010	Wallace JM, Erickson B, Les CM, Orr BG, Banaszak Holl MM. Distribution of type I collagen morphologies in bone: relation to estrogen depletion. Bone. May 2010;46(5):1349-1354.
2005	Felsenberg D, Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther. January 2005;27(1):1-11.
1981	Chatterji S, Wall JC, Jeffery JW. Age-related changes in the orientation and particle size of the mineral phase in human femoral cortical bone. Calcif Tiss Int. December 1981;33(6):567-574.
2011	Burket J, Gourion-Arsiquaud S, Havill LM, Baker SP, Boskey AL, van der Meulen MCH. Microstructure and nanomechanical properties in osteons relate to tissue and animal age. J Biomech. January 11, 2011;44(2):277-284.
2003	Tong W, Glimcher MJ, Katz JL, Kuhn L, Eppell SJ. Size and shape of mineralites in young bovine bone measured by atomic force microscopy. Calcif Tiss Int. May 2003;72(5):592-598.
2010	Donnelly E, Boskey AL, Baker SP, van der Meulen MCH. Effects of tissue age on bone tissue material compositionand nanomechanical properties in the rat cortex. J Biomed Mater Res. March 1, 2010;A92(3):1048-1056.
2000	Carden A, Morris MD. Application of vibrational spectroscopy to the study of mineralized tissues (review). J Biomed Opt. July 2000;5(3):259-268.
1998	Penel G, Leroy G, Rey C, Bres E. MicroRaman spectral study of the PO₄ and CO₃ vibrational modes in synthetic and biological apatites. Calcif Tiss Int. December 1998;63(6):475-481.
2002	Aparicio S, Doty SB, Camacho NP, Paschalis EP, Spevak L, Mendelsohn R, Boskey AL. Optimal methods for processing mineralized tissues for Fourier transform infrared microspectroscopy. Calcif Tiss Int. May 2002;70(5):422-429.
2001	Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mellström D, Oefjord ES, Marcinowska-Suchowierska E, Salmi J, Mulder H, Halse J, Sawicki AZ, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. NEJM. May 10, 2001;344(19):1434-1441.
1999	Baig AA, Fox JL, Young RA, Wang Z, Hsu J, Higuchi WI, Chhettry A, Zhuang H, Otsuka M. Relationships among carbonated apatite solubility, crystallite size, and microstrain parameters. Calcif Tiss Int. May 1999;64(5):437-449.
2008	Ruppel ME, Miller LM, Burr DB. The effect of the microscopic and nanoscale structure on bone fragility. Osteoporos Int. September 2008;19(9):1251-1265.
2009	Meganck JA, Kozloff KM, Thornton MM, Broski SM, Goldstein SA. Beam hardening artifacts in micro-computed tomography scanning can be reduced by X-ray beam filtration and the resulting images can be used to accurately measure BMD. Bone. December 2009;45(6):1104-1116.
2005	Boskey AL, DiCarlo E, Paschalis E, West P, Mendelsohn R. Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int. December 2005;16(12):2031-2038.
1999	Camacho NP, Hou L, Toledano TR, Ilg WA, Brayton CF, Raggio CL, Root L, Boskey AL. The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res. February 1999;14(2):264-272.
2005	Ager JW III, Nalla RK, Breeden KL, Ritchie RO. Deep-ultraviolet Raman spectroscopy study of the effect of aging on human cortical bone. J Biomed Opt. May–June 2005;10(3):034012.
2008	Russell RGG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. June 2008;19(6):733-759.
2001	Eppell SJ, Tong W, Katz JL, Kuhn L, Glimcher MJ. Shape and size of isolated bone mineralites measured using atomic force microscopy. J Orthop Res. November 2001;19(6):1027-1034.
2006	McCreadie BR, Morris MD, Chen T-c, Rao DS, Finney WF, Widjaja E, Goldstein SA. Bone tissue compositional differences in women with and without osteoporotic fracture. Bone. December 2006;39(6):1190-1195.
2009	Wallace JM, Golcuk K, Morris MD, Kohn DH. Inbred strain-specific response to biglycan deficiency in the cortical bone of C57BL6/129 and C3H/He mice. J Bone Miner Res. June 2009;24(6):1002-1012.
2006	Yerramshetty JS, Lind C, Akkus O. The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade. Bone. December 2006;39(6):1236-1243.
2007	Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin‐deficient mice. J Bone Miner Res. February 2007;22(2):286-297.
2006	Silva MJ, Brodt MD, Wopenka B, Thomopoulos S, Williams D, Wassen MH, Ko M, Kusano N, Bank RA. Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the samp6 mouse. J Bone Miner Res. January 2006;21(1):78-88.
1997	Paschalis EP, Betts F, DiCarlo E, Mendelsohn R, Boskey AL. FTIR microspectroscopic analysis of human iliac crest biopsies from untreated osteoporotic bone. Calcif Tiss Int. December 1997;61(6):487-492.
2004	Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res. April 2004;19(4):614-622.
2011	Morris MD, Mandair GS. Raman assessment of bone quality. Clin Orthop Relat Res. August 2011;469:2160-2169.
1973	Katz EP, Li S-T. Structure and function of bone collagen fibrils. J Mol Biol. October 15, 1973;80(1):1-15.
2002	Tarnowski CP, Ignelzi MA Jr, Morris MD. Mineralization of developing mouse calvaria as revealed by Raman microspectroscopy. J Bone Miner Res. June 2002;17(6):1118-1126.
2004	Akkus O, Adar F, Schaffler MB. Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone. March 2004;34(4):443-453.
1991	Pleshko N, Boskey A, Mendelsohn R. Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals. Biophys J. October 1991;60(4):786-793.
2005	Riggs BL, Parfitt AM. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res. February 2005;20(2):177-184.
2011	Chen P-Y, Toroian D, Price PA, McKittrick J. Minerals form a continuum phase in mature cancellous bone. Calcif Tiss Int. May 2011;88(5):351-361.
2003	Akkus O, Polyakova‐Akkus A, Adar F, Schaffler MB. Aging of microstructural compartments in human compact bone. J Bone Miner Res. June 2003;18(6):1012-1019.
2007	Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S; HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture. NEJM. November 1, 2007;357(18):1799-1809.

Year

Entry

2000

Rauch F, Travers R, Parfitt AM, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. June 2000;26(6):581-589.

2004

Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. April 24, 2004;363(9418):1377-1385.

2010

Nudelman F, Pieterse K, George A, Bomans PHH, Friedrich H, Brylka LJ, Hilbers PAJ, de With G, Sommerdijk NAJM. The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater. December 2010;9(12):1004-1009.

2010

Boskey AL, Coleman R. Aging and bone. J Dent Res. December 2010;89(2):1333-1348.

2006

Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RGG, Ebetino FH. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone. May 2006;38(5):617-627.